Liver cancer or hepatocellular carcinoma (HCC) is leading cause of cancer-related
mortalities globally. The therapeutic approaches for chronic liver diseases-associated liver …

Viral hepatitis with hepatitis C virus or hepatitis B virus and chronic liver disease such as
alcoholic or nonalcoholic steatohepatitis are critical factors in the development of …

Hepatocellular carcinoma (HCC) is the most common type of liver cancer worldwide. Viral
hepatitis is a significant risk factor for HCC, although metabolic syndrome and diabetes are …

Background Peroxisome proliferator-activated receptor-beta/delta (PPARδ) was considered
as the key regulator involved in the evolution of various tumors. Given that PPARδ potential …

Peroxisome proliferator-activated receptor alpha (PPARα) ligands have been reported to
suppress cancer growth. However, the role of PPARα in hepatocarcinogenesis remains …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer‐related death
worldwide. This cancer develops mainly in cirrhotic patients. The cirrhotic liver is considered …

Hepatocellular carcinoma (HCC) is the major leading cause of cancer death worldwide.
Hepatitis B virus, hepatitis C virus, alcohol consumption, non-alcoholic fatty liver disease …

Background The peroxisome proliferator-activated receptor alpha (PPARα) is a ligand-
activated transcription factor that regulates lipid catabolism and inflammation and is …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Major risk
factors of HCC include infection with hepatitis B or C viruses, alcohol and non‐alcoholic fatty …

Although peroxisome proliferator‐activated receptor gamma (PPARγ) agonist have been
shown to inhibit hepatocellular carcinoma (HCC) development, the role of PPARγ in …